Fusion Pharmaceuticals Inc

NASDAQ FUSN

Data sourced from iex and EODHD
Download Data

Fusion Pharmaceuticals Inc Income Statement 2000 - 2024

This table shows the Income Statement for Fusion Pharmaceuticals Inc going from 2000 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2000-09-30 2000-06-30 2000-03-31
Revenue
M 0 34 2 0 0 0 0 1 1 1 0 1 0 0 0 0 0 0 0 - - 0 - -
Cost of Revenue
M 0 0 1 1 16 18 - - - - - - - - - - - - - - - - - -
Gross Profit
M 0 33 1 -1 -16 -17 0 1 1 1 0 1 - - - - - - - - - - - -
Operating Expenses
M 35 62 20 26 9 7 24 20 21 18 20 28 - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 15 8 7 8 9 7 7 8 8 6 7 7 7 7 6 4 4 3 2 2 1 2 4 3
Research and Development (R&D) Expenses
M 21 20 15 19 16 18 17 12 13 12 13 21 11 5 5 3 4 3 2 2 3 1 1 2
Other Operating Expenses
M 0 34 -1 -1 -16 -18 0 0 0 0 0 0 - - - - - - - - - - - -
Costs and Expenses
M 35 28 20 26 9 7 - - - - - - - - - - - - - - - - - -
Operating Income
M -36 -28 -19 -27 -25 -24 -24 -19 -21 -18 -20 -27 -18 -12 -10 -7 -9 -6 -4 -4 -4 - - -
Interest Expense
M 2 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 - - - - - - -
Non-operating Income/Expense
M 2 1 2 0 1 -1 -1 0 1 0 0 0 0 1 0 -37 -2 -2 3 0 0 - - -
EBT
M -34 -27 -18 -25 -24 -25 -25 -20 -20 -17 -19 -27 -18 -11 -10 -45 -10 -8 0 -3 -4 - - -
Income Tax Provision
M 0 1 0 0 0 0 -1 -1 0 0 0 0 0 3 0 0 0 0 0 0 0 - - -
Income after Tax
M -34 -28 -17 -25 -24 -25 -24 -19 -20 -17 -19 -27 -18 -13 -10 -45 -10 -8 -1 -3 -4 - - -
Non-Controlling Interest
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 - - - - -
Net Income
M - - -17 -25 -24 -25 -24 -19 -20 -17 -19 -27 -18 -13 -10 -45 -12 -16 -1 -3 -4 - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 83,775,652.00 73,094,249.00 69,050,107.00 66,277,278.00 53,775,985.00 44,766,314.00 43,683,738.00 43,357,240.00 43,170,076.00 43,066,953.00 43,022,762.00 42,501,321.00 41,784,269.00 41,722,234.00 41,682,797.00 2,366,198.00 41,664,044.00 21,303,335.00 21,303,335.00 21,303,335.00 21,303,335.00 - - -
EBITDA
M -35 -28 -19 -24 -23 -24 -24 -19 -20 -18 -19 -27 -18 -12 -10 -1 -8 -6 -4 -4 -4 - - -
Depreciation and Amortization
M 0 0 0 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - -
EBIT
M -36 -28 -20 -24 -25 -24 -24 -19 -21 -18 -20 -27 -18 -12 -10 -1 -8 -6 -4 -4 -4 - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.70 -4.82 1.45 0.96 0.05 1.36 3.07 3.45 0.28 0.99 -0.25 -0.05 0.04 -23.92 1.82 -0.34 -0.61 -0.47 -43.83 -0.52 -0.36 - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - -
Gross Profit Margin
% - 98.93 47.96 -2,638.24 -56,603.57 -12,476.43 100.00 100.00 100.00 100.00 100.00 100.00 - - - - - - - - - - - -
Operating Income Margin
% - -84.06 -966.55 -78,567.65 -88,767.86 -17,440.71 -14,340.36 -3,383.68 -3,508.55 -2,955.05 -6,004.62 -5,233.59 - - - - - - - - - - - -
Net Income Margin
% - - -860.02 -74,044.12 -86,753.57 -17,583.57 -14,465.66 -3,346.14 -3,403.25 -2,901.68 -5,978.15 -5,154.13 - - - - - - - - - - - -
EBITDA Ratio
% - -82.99 -966.55 -70,002.94 -82,425.00 -16,991.43 -14,194.58 -3,345.79 -3,473.85 -2,955.05 -5,947.69 -5,204.03 - - - - - - - - - - - -
EBIT Ratio
% - -84.06 -985.19 -70,994.12 -88,767.86 -17,440.71 -14,340.36 -3,383.68 -3,508.55 -2,986.03 -6,004.62 -5,233.59 - - - - - - - - - - - -
EBT Ratio
% - -79.92 -872.63 -74,764.71 -86,792.86 -17,826.43 -14,924.10 -3,465.61 -3,412.65 -2,930.81 -5,963.38 -5,151.44 - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email